UnitedHealth Group Incorporated ( NYSE:UNH – Get Free Report ) has been given an average recommendation of “Buy” by the twenty-two analysts that are presently covering the company, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation, nineteen have assigned a buy recommendation and two have assigned a strong buy recommendation to the company.
The average 12 month price target among brokerages that have issued a report on the stock in the last year is $627.74. A number of equities analysts recently issued reports on UNH shares.
Bank of America dropped their price objective on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th.
StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday. Royal Bank of Canada cut their price target on UnitedHealth Group from $615.
00 to $595.00 and set an “outperform” rating for the company in a report on Wednesday, October 16th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $700.
00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. Finally, Barclays reduced their target price on shares of UnitedHealth Group from $655.00 to $642.
00 and set an “overweight” rating for the company in a report on Friday, January 17th. Read Our Latest Report on UNH UnitedHealth Group Price Performance UnitedHealth Group ( NYSE:UNH – Get Free Report ) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.
81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07.
UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%.
The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion.
During the same period last year, the business posted $5.83 EPS. The company’s revenue for the quarter was up 6.
8% on a year-over-year basis. On average, sell-side analysts forecast that UnitedHealth Group will post 29.74 EPS for the current year.
UnitedHealth Group Dividend Announcement The company also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were given a dividend of $2.10 per share.
The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.
58%. UnitedHealth Group’s payout ratio is 54.19%.
Insiders Place Their Bets In related news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, for a total transaction of $511,570.
00. Following the completion of the purchase, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.
57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link . 0.
33% of the stock is owned by insiders. Hedge Funds Weigh In On UnitedHealth Group Several large investors have recently bought and sold shares of the business. Dark Forest Capital Management LP lifted its position in shares of UnitedHealth Group by 76.
9% during the 2nd quarter. Dark Forest Capital Management LP now owns 734 shares of the healthcare conglomerate’s stock worth $374,000 after buying an additional 319 shares during the last quarter. Scientech Research LLC purchased a new stake in UnitedHealth Group in the second quarter valued at $1,071,000.
Sepio Capital LP increased its position in shares of UnitedHealth Group by 0.3% during the second quarter. Sepio Capital LP now owns 5,822 shares of the healthcare conglomerate’s stock worth $2,965,000 after purchasing an additional 20 shares in the last quarter.
Texas Capital Bank Wealth Management Services Inc boosted its position in shares of UnitedHealth Group by 6.6% in the 2nd quarter. Texas Capital Bank Wealth Management Services Inc now owns 16,134 shares of the healthcare conglomerate’s stock valued at $8,216,000 after purchasing an additional 994 shares during the period.
Finally, Kathmere Capital Management LLC increased its position in UnitedHealth Group by 25.1% during the second quarter. Kathmere Capital Management LLC now owns 4,768 shares of the healthcare conglomerate’s stock worth $2,428,000 after buying an additional 958 shares during the period.
Hedge funds and other institutional investors own 87.86% of the company’s stock. About UnitedHealth Group ( Get Free Report UnitedHealth Group Incorporated operates as a diversified health care company in the United States.
The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. Further Reading Five stocks we like better than UnitedHealth Group What is the Nasdaq? Complete Overview with History Bloom Energy: Powering the Future With Decentralized Energy What Are Dividend Contenders? Investing in Dividend Contenders Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul How to trade using analyst ratings Why Traders Are Buying the Dip on Johnson & Johnson Stock Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.
com's FREE daily email newsletter ..
Business
UnitedHealth Group Incorporated (NYSE:UNH) Given Consensus Rating of “Buy” by Brokerages
UnitedHealth Group Incorporated (NYSE:UNH – Get Free Report) has been given an average recommendation of “Buy” by the twenty-two analysts that are presently covering the company, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation, nineteen have assigned a buy recommendation and two have assigned a strong buy recommendation to the company. [...]